Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

UCLA Health Study Identifies Strategy to Boost Strength and Longevity of Cancer Fighting T Cells

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a promising new strategy to make cancer-fighting immune cells stronger and potentially longer-lasting, a discovery that could help improve the effectiveness of immunotherapies that use a patient's own immune cells to attack cancer.

31 Oct 2026

Adalvo Expands Biosimilars Portfolio Through Acquisition of Romiplostim Biosimilar Program From Enzene

Adalvo today announced the acquisition of a romiplostim biosimilar program referencing Nplate® from Enzene, strengthening its biosimilars portfolio and accelerating the company’s expansion into complex biological medicines.

From Adalvo 28 Oct 2026

Alcami Announces Promotion of Robert Tragas to Vice President, Laboratory Services

Alcami, a leading contract development and manufacturing organization (CDMO), today announced its strengthening of laboratory leadership with the promotion of Robert Tragas to Vice President, Laboratory Services.

28 Oct 2026

Researchers Develop Predictive Model for Mass Spectrometry Imaging

Andrei Fedorov and his team have found a way to take some of the guesswork out of mass spectrometry imaging (MSI), potentially giving scientists better tools to explore the molecules that influence our health.

27 Oct 2026

BioNTech Opens mRNA Manufacturing Facility at La Trobe

La Trobe University is now home to one of the world’s leading biopharmaceutical companies, with the official opening of BioNTech’s state-of-the-art, clinical-scale mRNA manufacturing and research facility at the University’s campus in Melbourne’s north.

From BioNTech SE 22 Oct 2026

INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar

INmune Bio Inc. (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into a Master Services Agreement with Uniphar Durbin Ireland Limited (“Uniphar”) establishing a scalable framework to support international access, distribution and commercialization of Ebstrocel™, the Company’s allogeneic stromal cell therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB).

From INmune Bio 22 Oct 2026

Touchlight Announces Leadership Transition, with Will Downie Appointed Interim CEO

Touchlight today announces that Karen Fallen is stepping down as CEO and that the Board of Directors has appointed Will Downie as Interim Chief Executive Officer.

From Touchlight 21 Oct 2026

Cedars-Sinai Expands Stem Cell Research Aboard the Space Station

When NASA’s SpaceX CRS-35 mission docks with the International Space Station Oct. 15, it will deliver two experiments from the Cedars-Sinai Center for Space Medicine Research.

16 Oct 2026

Using Bacteria to Create Biocement Materials

Cement manufacturing is one of the largest sources of CO2 emissions in the construction industry. At the Department of Architecture, Karen Antorveza Paez, who has just completed her doctorate at ETH Zurich, is researching an alternative that works in a totally different way: instead of firing rocks at over 1,000°C, she is getting bacteria to bond grains of sand together into solid architectural elements.

16 Oct 2026

Comprehensive Analysis of Emerging Strategies for Targeting Cyclin-Dependent Kinases in Cancer

More than 30 years after the direct connection was established between the molecular machinery controlling cell division and cancer, a new paper traces the evolution of cyclin-dependent kinase research and outlines the next generation of CDK-targeted therapies.

15 Oct 2026

Lipid Nanoparticles Reprogram NK Cells Internally to Eliminate Cancerous T Cells

MIT engineers have developed a new way to program natural killer (NK) immune cells to target cancerous T cells or T cells that have become autoreactive, leading to diseases such as lymphoma and autoimmune hepatitis.

14 Oct 2026

India's Pharma Industry Looks Beyond US as Trade Uncertainty Grows, Says GlobalData

India's pharmaceutical manufacturing industry is entering a delicate phase in its development. As uncertainty grows over its long-term access to the US market, the country is gaining improved access to other major overseas markets, says GlobalData, a leading intelligence and productivity platform.

9 Oct 2026

Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development

Bio-Techne Corporation, a global provider of life science tools, reagents and diagnostic products, today announced the opening of a new manufacturing facility for Good Manufacturing Practice (GMP) grade small molecules in Bristol, United Kingdom, further expanding the company's global capabilities to support the rapidly growing cell therapy market.

From Bio-Techne 8 Oct 2026

Formycon Optimizes Biosimilar Development with AI-Powered Technologies: Digital Solutions Enhance Development Efficiency as Part of the FYB4GROWTH Strategy

Formycon AG ("Formycon") is enhancing the efficiency and scalability of its biosimilar development activities through the focused use of digital technologies.

7 Oct 2026

BioDuro Appoints Greg Makara as Senior Vice President Lead Discovery Chemistry to Strengthen Early Drug Discovery Capabilities

BioDuro, a global integrated contract research, development and manufacturing organization (CRDMO), today announced the appointment of Greg Makara, Ph.D., as Senior Vice President Lead Discovery Chemistry.

From BioDuro 5 Oct 2026

ESTEVE CDMO Expands U.S. Capacity with Additional $17.5 Million Investment in Morton Grove

ESTEVE CDMO, a global pure-play CDMO specializing in the development and manufacture of small-molecule APIs and pharmaceutical intermediates, has approved an additional $17.5 million capacity expansion and containment capabilities at its Morton Grove, Illinois facility, bringing total announced investment at the site to $33 million.

From ESTEVE CDMO 5 Oct 2026

MedPharm Inks Deal to Support Global Pharmaceutical Company with Commercial Site Transfer

MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, today announced that it has signed a new agreement with a global pharmaceutical company to support the commercial site transfer and commercial manufacturing of their branded specialty topical pharmaceutical product.

From MedPharm 5 Oct 2026

OnDosis and Adare Pharma Solutions Announce Strategic Collaboration to Advance OnDosis's Lead U.S. ADHD Program

OnDosis AB ("OnDosis"), a Swedish life science company developing drug device combinations for precision dosing of oral solid medicines based on the Dosage Manager device platform, and Adare Pharma Solutions ("Adare"), a technology-driven, integrated contract development and manufacturing organization (CDMO), today announced a strategic collaboration.

From OnDosis AB 1 Oct 2026

Lifeblood, UQ and SMART CRC Pump New Life Into Lab-Grown Blood Production

Lifeblood researchers are among only a few research groups in the world who are already growing fully functional red blood cells from donor stem cells in the lab but producing them in quantities large enough for use in patients is inefficient and expensive.

29 Sep 2026

Integrated DNA Technologies and Aldevron Launch New Cas9 mRNA Solutions to Accelerate Path From Gene Editing Research to Development

Danaher companies Integrated DNA Technologies (IDT), a global leader in genomics, and Aldevron, a premier manufacturing partner for DNA, RNA, and protein, today announced the launch of research grade S.p. Cas9 mRNA in wild type and SpyFi™ high-fidelity formats.

From Integrated DNA Technologies 18 Sep 2026